Stay updated on Venetoclax and Dinaciclib in AML Clinical Trial

Sign up to get notified when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax and Dinaciclib in AML Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the study record for venetoclax and dinaciclib in relapsed/refractory acute myeloid leukemia, including its eligibility criteria, locations, design, and outcome measures, in place of an error response.
    Difference
    58%
    Check dated 2026-11-07T15:56:25.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.2 to v3.8.0; the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T16:22:01.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T18:55:04.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2; the page remains a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T18:24:38.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T19:20:58.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now shown with a minimal HTML header and a Home link, signaling that access to the study record is blocked. This replaces the previous content that displayed the study details.
    Difference
    0.5%
    Check dated 2026-09-26T20:04:34.000Z thumbnail image

Stay in the know with updates to Venetoclax and Dinaciclib in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.